Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Intercept Pharmaceuticals Raises FY21 Worldwide Ocaliva Sales Guidance From $325M-$340M To $355M-$370M Vs. $339.04M Est.


Benzinga | Nov 3, 2021 09:15AM EDT

Intercept Pharmaceuticals Raises FY21 Worldwide Ocaliva Sales Guidance From $325M-$340M To $355M-$370M Vs. $339.04M Est.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC